Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo

Human Gene Therapy

Volumn 18, Issue 1, 2007, Pages 81-87

  Yan, Ziying ^a   Lei Butters, Diana C M ^a   Zhang, Yulong ^a   Zak, Roman ^a   Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PARVOVIRUS VECTOR; PROTEASOME; PROTEASOME INHIBITOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME MODIFICATION; ENZYME REGULATION; EXON; GENE; GENE CONSTRUCT; GENE EXPRESSION; GENE VECTOR; GENETIC ANALYSIS; GENETIC RECOMBINATION; HEART; HOMOLOGOUS RECOMBINATION; IN VIVO STUDY; INVERTED TERMINAL REPEAT; LACZ GENE; LIVER; MOUSE; MOUSE STRAIN; NONHUMAN; SEQUENCE ANALYSIS; SKELETAL MUSCLE; TRANS SPLICING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENETICS; VIRUS HYBRID; VIRUS RECOMBINATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; DEPENDOVIRUS; DOXORUBICIN; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; GENOME, VIRAL; LAC OPERON; MICE; TERMINAL REPEAT SEQUENCES; TRANS-SPLICING; TRANSDUCTION, GENETIC; TRANSGENES;

ADENO-ASSOCIATED VIRUS;

EID: 33846192000     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.128     Document Type: Article

References (22)

1. BERNS, K.I., and GIRAUD, C. (1996). Adeno-associated Virus (AAV) Vectors in Gene Therapy. (Springer-Verlag, Berlin).
2. CARTER, B.J. (2000). Adeno-associated viruses as gene transfer vehicles. Contrib. Microbiol. 4, 85-106.
3. CHEN, Z.Y., YANT, S.R., HE, C.Y., MEUSE, L., SHEN, S., and KAY, M.A. (2001). Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol. Ther. 3, 403-410.
4. DING, W., YAN, Z., ZAK, R., SAAVEDRA, M., RODMAN, D.M., and ENGELHARDT, J.F. (2003). Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol. 77, 7361-7366.
5. DUAN, D., YUE, Y., YAN, Z., and ENGELHARDT, J.F. (2000a). A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med. 6, 595-598.
6. DUAN, D., YUE, Y., YAN, Z., YANG, J., and ENGELHARDT, J.F. (2000b). Endosomal processing limits gene transfer to polarized lairway epithelia by adeno-associated virus. J. Clin. Invest. 105, 1573-1587.
7. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2001). Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol. Ther. 4, 383-391.
8. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2003a). Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. J. Virol. 77, 4751-4759.
9. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2003b). Dual vector expansion of the recombinant AAV packaging capacity. Methods Mol. Biol. 219, 29-51.
10. GRIMM, D., PANDEY, K., NAKAI, H., STORM, T.A., and KAY, M.A. (2006). Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J. Virol. 80, 426-439.
11. LAI, Y., YUE, Y., LIU, M., GHOSH, A., ENGELHARDT, J.F., CHAMBERLAIN, J.S., and DUAN, D. (2005). Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol. 23, 1435-1439.
12. LIU, M., YUE, Y., HARPER, S.Q., GRANGE, R.W., CHAMBERLAIN, J.S., and DUAN, D. (2005). Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol. Ther. 11, 245-256.
13. NAKAI, H., STORM, T.A., and KAY, M.A. (2000). Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors [see comments]. Nat. Biotechnol. 18, 527-532.
14. NAKAI, H., MONTINI, E., FUESS, S., STORM, T.A., MEUSE, L., FINEGOLD, M., GROMPE, M., and KAY, M.A. (2003). Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. Mol. Ther. 7, 101-111.
15. REICH, S.J., AURICCHIO, A., HILDINGER, M., GLOVER, E., MAGUIRE, A.M., WILSON, J.M., and BENNETT, J. (2003). Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy. Hum. Gene Ther. 14, 37-44.
16. SUN, L., LI, J., and XIAO, X. (2000). Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6, 599-602.
17. YAN, Z., ZHANG, Y., DUAN, D., and ENGELHARDT, I.F. (2000). From the Cover: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 97, 6716-6721.
18. YAN, Z., RITCHIE, T.C., DUAN, D., and ENGELHARDT, J.F. (2002). Recombinant AAV-mediated gene delivery using dual vector heterodimerization. Methods Enzymol. 346, 334-357.
19. YAN, Z., ZAK, R., ZHANG, Y., DING, W., GODWIN, S., MUNSON, K., PELUSO, R., and ENGELHARDT, J.F. (2004). Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J. Virol. 78, 2863-2874.
20. YAN, Z., ZAK, R., ZHANG, Y., and ENGELHARDT, J.F. (2005). Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes. J. Virol. 79, 364-379.
21. YAN, Z., LEI-BUTTERS, D.C., LIU, X., ZHANG, Y., ZHANG, L., LUO, M., ZAK, R., and ENGELHARDT, J.F. (2006). Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia. J. Biol. Chem. 281, 29684-29692.
22. YANG, J., ZHOU, W., ZHANG, Y., ZIDON, T., RITCHIE, T., and ENGELHARDT, J.F. (1999). Concatamerization of adeno-associated viral circular genomes occurs through intermolecular recombination. J. Virol. 73, 9468-9477.